<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00958529</url>
  </required_header>
  <id_info>
    <org_study_id>0805M32121</org_study_id>
    <nct_id>NCT00958529</nct_id>
  </id_info>
  <brief_title>Gastrointestinal Toleration of Inulin Products</brief_title>
  <official_title>Effect of Two Doses of Inulin Products on Gastrointestinal Tolerance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cargill</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intake of inulin products has been linked to multiple health benefits which has lead to&#xD;
      inulin fortification in food products.&#xD;
&#xD;
      The investigators hypothesis that doses of up to 10 grams of inulin products should be well&#xD;
      tolerated and not result in a significant increase in gastrointestinal symptoms.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      0, 5, and 10 grams of inulin&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastrointestinal Tolerance Score</measure>
    <time_frame>Aug 2008 thru Oct 2008</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>inulin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0, 5, 10 g inulin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Inulin Fiber Supplement</intervention_name>
    <description>Orange juice fortified with 0, 5g, and 10g of 2 inulin products</description>
    <arm_group_label>inulin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  english speaking&#xD;
&#xD;
          -  healthy men and women&#xD;
&#xD;
          -  18 and 60 years of age&#xD;
&#xD;
          -  non-smoking&#xD;
&#xD;
          -  non-dieting&#xD;
&#xD;
          -  BMI less than 30&#xD;
&#xD;
          -  standard diet consisting of no more than 15 grams fiber&#xD;
&#xD;
          -  not taking medications&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI more than 30&#xD;
&#xD;
          -  CVD&#xD;
&#xD;
          -  Diabetes Mellitus&#xD;
&#xD;
          -  cancer in prior 5 years&#xD;
&#xD;
          -  renal or hepatic disease&#xD;
&#xD;
          -  bacterial infection in past 2 weeks&#xD;
&#xD;
          -  more than 5 kg weight loss in past 3 months&#xD;
&#xD;
          -  history of drug or alcohol abuse in past 6 months&#xD;
&#xD;
          -  use of weight loss, lipid-lowering, anti-hypertensive, or anti- inflammatory&#xD;
             medications&#xD;
&#xD;
          -  concurrent or recent intervention study participation&#xD;
&#xD;
          -  consumption of laxatives&#xD;
&#xD;
          -  history of gastrointestinal disorders&#xD;
&#xD;
          -  food allergies&#xD;
&#xD;
          -  pregnant or lactating women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joanne L Slavin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota: Nutrition and Food Science Department</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <study_first_submitted>August 12, 2009</study_first_submitted>
  <study_first_submitted_qc>August 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2009</study_first_posted>
  <last_update_submitted>February 9, 2017</last_update_submitted>
  <last_update_submitted_qc>February 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fiber</keyword>
  <keyword>inulin</keyword>
  <keyword>gastrointestinal tolerance</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

